Alcon (ALC) Other Non-Current Liabilities (2009 - 2026)
Alcon (ALC) posted quarterly Other Non-Current Liabilities of $933.0 million for Q1 2026, down 0.64% on a QoQ basis from $939.0 million in Q4 2025.
Alcon (ALC) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Other Non-Current Liabilities for 11 consecutive years, with $933.0 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $933.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $933.0 million (changed N/A YoY) and the FY2025 annual result came in at $939.0 million, up 13.82% from the prior year.
- Other Non-Current Liabilities eased to $933.0 million in Q1 2026 per ALC's latest filing, from $939.0 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for ALC reached as high as $944.0 million in Q3 2025 and fell as low as -$260.0 million in Q4 2023.
- A 5-year average of $658.0 million and a median of $783.5 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities slumped 239.04% — and 2025, when it soared 1179.31%.
- Year by year, Other Non-Current Liabilities stood at $187.0 million in 2022, then sank by 239.04% to -$260.0 million in 2023, then jumped by 66.54% to -$87.0 million in 2024, then surged by 1179.31% to $939.0 million in 2025, then declined by 0.64% to $933.0 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $933.0 million, $939.0 million, and $944.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 933.00 Mn |
| Dec 31, 2025 | 939.00 Mn |
| Sep 30, 2025 | 944.00 Mn |
| Jun 30, 2025 | 872.00 Mn |
| Dec 31, 2024 | -87.00 Mn |
| Sep 30, 2024 | 799.00 Mn |
| Jun 30, 2024 | 763.00 Mn |
| Mar 31, 2024 | 768.00 Mn |
| Dec 31, 2023 | -260.00 Mn |
| Sep 30, 2023 | 727.00 Mn |
| Jun 30, 2023 | 832.00 Mn |
| Mar 31, 2023 | 816.00 Mn |
| Dec 31, 2022 | 187.00 Mn |
| Sep 30, 2022 | 707.00 Mn |
| Jun 30, 2022 | 743.00 Mn |
| Mar 31, 2022 | 845.00 Mn |
| Dec 31, 2021 | 940.00 Mn |
| Sep 30, 2021 | 969.00 Mn |
| Jun 30, 2021 | 1.02 Bn |
| Mar 31, 2021 | 1.01 Bn |